Frone et al.

Author Manuscript

# References

Moos RH (2007a). Theory‑based active ingredients of effective treatments for substance use disorders. Drug and Alcohol Dependence, 88(2–3), 109–121. doi:10.1016/j.drugalcdep.2006.10.010 [PubMed: 17129682]

Moos RH (2007b). Theory‑based processes that promote the remission of substance use disorders. Clinical Psychology Review, 27(5), 537–551. doi:10.1016/j.cpr.2006.12.006 [PubMed: 17254686]

Muller CP (2020). Drug instrumentalization. Behavioural Brain Research, 390, 112672. doi:10.1016/j.bbr.2020.112672 [PubMed: 32442549]

Muller CP, & Schumann G (2011). Drugs as instruments: A new framework for non‑addictive psychoactive drug use. Behavioral and Brain Sciences, 34(6), 293–310. doi:10.1017/S0140525X11000057 [PubMed: 22074962]

National Academies of Sciences‑Engineering‑Medicine. (2016a). Ending discrimination against people with mental and substance use disorders: The evidence for stigma change Washington, DC: The National Academies Press

National Academies of Sciences‑Engineering‑Medicine. (2016b). Measuring recovery from substance use or mental disorders: Workshop summary Washington, DC: The National Academies Press

National Drug Intelligence Center. (2011). The Economic Impact of Illicit Drug Use on American Society Washington D.C: United States Department of Justice

National Institute for Occupational Safety and Health (2019). Medication‑assisted therapy for opioid disorder doi:10.26616/NIOSHPUB2019133

National Institute on Drug Abuse (2018). Drugs, brains, and behavior: The science of addiction Bethesda, MD: National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services. Retrieved from https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/soa.pdf

National Safety Council. (2017). How the prescription drug crisis is impacting American employers Itasca, IL: National Safety Council

National Safety Council. (2019). National employer survey 2019: Opioid usage in the workplace Itasca, IL: National Safety Council

Nieweglowski K, Corrigan PW, Tyas T, Tooley A, Dubke R, Lara J, & Sheehan L (2018). Exploring the public stigma of substance use disorder through community‑based participatory research. Addiction Research & Theory, 26, 323–329. doi:10.1080/16066359.2017.1409890

O’Brien CP, & McLellan AT (1996). Myths about the treatment of addiction. Lancet, 347(8996), 237–240. doi:10.1016/s0140‑6736(96)90409‑2 [PubMed: 8551886]

O’Neill OA, Vandenberg RJ, Dejoy DM, & Wilson MG (2009). Exploring relationships among anger, perceived organizational support, and workplace outcomes. Journal of Occupational Health Psychology, 14(3), 318–333. doi:10.1037/a0015852 [PubMed: 19586225]

O’Sullivan D, Xiao Y, & Watts JR (2019). Recovery capital and quality of life in stable recovery from addiction. Rehabilitation Counseling Bulletin, 62, 209–221. doi:10.1177/0034355217730395

Office of the Surgeon General. (2016). Facing addiction in America: The surgeon general’s report on alcohol, drugs, and health Washington, DC: U.S. Department of Health and Human Services

Pidd K, Kostadinov V, & Roche A (2016). Do workplace policies work? An examination of the relationship between alcohol and other drug policies and workers’ substance use. International Journal of Drug Policy, 28, 48–54. doi:10.1016/j.drugpo.2015.08.017 [PubMed: 26410610]

Radacsi G, & Hardi P (2014). Substance misuse prevention as corporate social responsibility. Substance Use & Misuse, 49(4), 352–363. doi:10.3109/10826084.2013.841242 [PubMed: 24093521]

Ramo DE, & Brown SA (2008). Classes of substance abuse relapse situations: A comparison of adolescents and adults. Psychology of Addictive Behaviors, 22(3), 372–379. doi:10.1037/0893‑164X.22.3.372

Rasinski KA, Woll P, & Cooke A (2005). Stigma and substance use disorders. In Corrigan PW (Ed.), On the stigma of mental illness: Practical strategies for research and social change (pp. 219–236). Washington, DC: American Psychological Association

Robinson SM, & Adinoff B (2018). The mixed message behind “Medication‑Assisted Treatment” for substance use disorder. American Journal of Drug and Alcohol Abuse, 44(2), 147–150. doi:10.1080/00952990.2017.1362419 [PubMed: 28920715]

Occup Health Sci. Author manuscript; available in PMC 2023 May 18.